Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 34
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Uher, Rudolf and Rutter, Michael 2012. Basing psychiatric classification on scientific foundation: Problems and prospects. International Review of Psychiatry, Vol. 24, Issue. 6, p. 591.


    Dunn, Barnaby D. 2012. Helping Depressed Clients Reconnect to Positive Emotion Experience: Current Insights and Future Directions. Clinical Psychology & Psychotherapy, Vol. 19, Issue. 4, p. 326.


    Dunn, Barnaby D. and Roberts, Henrietta 2016. The Wiley Handbook of Positive Clinical Psychology.


    Cipriani, Andrea and Geddes, John 2016. Predicting treatment outcome in depression: so far, so good. The Lancet Psychiatry, Vol. 3, Issue. 3, p. 192.


    Pizzagalli, Diego A. 2014. Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model. Annual Review of Clinical Psychology, Vol. 10, Issue. 1, p. 393.


    Rayner, Genevieve Jackson, Graeme D. and Wilson, Sarah J. 2016. Two distinct symptom-based phenotypes of depression in epilepsy yield specific clinical and etiological insights. Epilepsy & Behavior,


    Uher, Rudolf Tansey, Katherine E Malki, Karim and Perlis, Roy H 2012. Biomarkers predicting treatment outcome in depression: what is clinically significant?. Pharmacogenomics, Vol. 13, Issue. 2, p. 233.


    Fried, Eiko I. and Nesse, Randolph M. 2015. Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. Journal of Affective Disorders, Vol. 172, p. 96.


    Lawson, R P Nord, C L Seymour, B Thomas, D L Dayan, P Pilling, S and Roiser, J P 2016. Disrupted habenula function in major depression. Molecular Psychiatry,


    Saland, Samantha K. Schoepfer, Kristin J. and Kabbaj, Mohamed 2016. Hedonic sensitivity to low-dose ketamine is modulated by gonadal hormones in a sex-dependent manner. Scientific Reports, Vol. 6, p. 21322.


    Fried, Eiko I and Nesse, Randolph M 2015. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Medicine, Vol. 13, Issue. 1,


    Fawcett, Jan 2015. Inflammation, Homocysteine, and Systems Biology in Psychiatry. Psychiatric Annals, Vol. 45, Issue. 9, p. 445.


    Fervaha, Gagan Foussias, George Takeuchi, Hiroyoshi Agid, Ofer and Remington, Gary 2016. Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being. Comprehensive Psychiatry, Vol. 66, p. 31.


    Rizvi, Sakina J. Sproule, Beth A. Gallaugher, Laura McIntyre, Roger S. and Kennedy, Sidney H. 2015. Correlates of benzodiazepine use in major depressive disorder: The effect of anhedonia. Journal of Affective Disorders, Vol. 187, p. 101.


    Olbert, Charles M. Rasmussen, Andrew Gala, Gary J. and Tupler, Larry A. 2016. Treatment outcome variation between depression symptom combinations in the STAR*D study. Journal of Affective Disorders, Vol. 201, p. 1.


    Uher, Rudolf Perlis, Roy H. Placentino, Anna Dernovšek, Mojca Zvezdana Henigsberg, Neven Mors, Ole Maier, Wolfgang McGuffin, Peter and Farmer, Anne 2012. SELF-REPORT AND CLINICIAN-RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER?. Depression and Anxiety, Vol. 29, Issue. 12, p. 1043.


    Bhagwagar, Zubin Torbeyns, Anne Hennicken, Delphine Zheng, Ming Dunlop, Boadie W. Mathew, Sanjay J. Khan, Arif Weisler, Richard Nelson, Craig Shelton, Richard Thase, Michael E. and Lane, Roger 2015. Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression. Journal of Clinical Psychopharmacology, p. 1.


    Calabrese, Joseph R. Fava, Maurizio Garibaldi, George Grunze, Heinz Krystal, Andrew D. Laughren, Thomas Macfadden, Wayne Marin, Robert Nierenberg, Andrew A. and Tohen, Mauricio 2014. Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. Journal of Affective Disorders, Vol. 168, p. 439.


    Beshai, Shadi Wallace, Laurel M. Mcdougall, Katrina H. Waldmann, Kristina and Stea, Jonathan N. 2016. Reduced Contact Cognitive-Behavioral Interventions for Adult Depression: A Review. The Journal of Psychology, Vol. 150, Issue. 2, p. 252.


    Wassink-Vossen, Sanne Noorthoorn, Eric O. Collard, Rose M. Comijs, Hannie C. Oude Voshaar, Richard C. and Naarding, Paul 2016. Value of Physical Activity and Sedentary Behavior in Predicting Depression in Older Adults. Journal of the American Geriatrics Society, Vol. 64, Issue. 3, p. 647.


    ×

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

  • R. Uher (a1), R. H. Perlis (a2), N. Henigsberg (a3), A. Zobel (a4), M. Rietschel (a5), O. Mors (a6), J. Hauser (a7), M. Z. Dernovsek (a8), D. Souery (a9), M. Bajs (a3), W. Maier (a4), K. J. Aitchison (a1), A. Farmer (a1) and P. McGuffin (a1)
  • DOI: http://dx.doi.org/10.1017/S0033291711001905
  • Published online: 20 September 2011
Abstract
Background

Symptom dimensions have not yet been comprehensively tested as predictors of the substantial heterogeneity in outcomes of antidepressant treatment in major depressive disorder.

Method

We tested nine symptom dimensions derived from a previously published factor analysis of depression rating scales as predictors of outcome in 811 adults with moderate to severe depression treated with flexibly dosed escitalopram or nortriptyline in Genome-based Therapeutic Drugs for Depression (GENDEP). The effects of symptom dimensions were tested in mixed-effect regression models that controlled for overall initial depression severity, age, sex and recruitment centre. Significant results were tested for replicability in 3637 adult out-patients with non-psychotic major depression treated with citalopram in level I of Sequenced Treatment Alternatives to Relieve Depression (STAR*D).

Results

The interest-activity symptom dimension (reflecting low interest, reduced activity, indecisiveness and lack of enjoyment) at baseline strongly predicted poor treatment outcome in GENDEP, irrespective of overall depression severity, antidepressant type and outcome measure used. The prediction of poor treatment outcome by the interest-activity dimension was robustly replicated in STAR*D, independent of a comprehensive list of baseline covariates.

Conclusions

Loss of interest, diminished activity and inability to make decisions predict poor outcome of antidepressant treatment even after adjustment for overall depression severity and other clinical covariates. The prominence of such symptoms may require additional treatment strategies and should be accounted for in future investigations of antidepressant response.

Copyright
Corresponding author
*Address for correspondence: Dr R. Uher, P080, SGDP, Institute of Psychiatry, 16 De Crespigny Park, London SE5 8AF, UK. (Email: rudolf.uher@kcl.ac.uk)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

AT Beck , CH Ward , M Mandelson , J Mock , J Erbaugh (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561571.

I Bjelland , SA Lie , AA Dahl , A Mykletun , E Stordal , HC Kraemer (2009). A dimensional versus a categorical approach to diagnosis: anxiety and depression in the HUNT 2 study. International Journal of Methods in Psychiatric Research 18, 128137.

AB Bruhl , T Kaffenberger , U Herwig (2010). Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology 35, 521533.

MWP Carney , M Roth , RF Garside (1965). The diagnosis of depressive syndromes and the prediction of E.C.T. response. British Journal of Psychiatry 111, 659674.

CH Chen , K Ridler , J Suckling , S Williams , CH Fu , E Merlo-Pich , E Bullmore (2007). Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry 62, 407414.

BA Deyi , AS Kosinski , SM Snapinn (1998). Power considerations when a continuous outcome variable is dichotomized. Journal of Biopharmaceutical Statistics 8, 337352.

S Dimidjian , SD Hollon , KS Dobson , KB Schmaling , RJ Kohlenberg , ME Addis , R Gallop , JB McGlinchey , DK Markley , JK Gollan , DC Atkins , DL Dunner , NS Jacobson (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658670.

M Fava , AJ Rush , JE Alpert , GK Balasubramani , SR Wisniewski , CN Carmin , MM Biggs , S Zisook , A Leuchter , R Howland , D Warden , MH Trivedi (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342351.

M Fava , LA Uebelacker , JE Alpert , AA Nierenberg , JA Pava , JF Rosenbaum (1997). Major depressive subtypes and treatment response. Biological Psychiatry 42, 568576.

GL Flett , K Vredenburg , L Krames (1997). The continuity of depression in clinical and nonclinical samples. Psychological Bulletin 121, 395416.

E Frank , RF Prien , RB Jarrett , MB Keller , DJ Kupfer , PW Lavori , AJ Rush , MM Weissman (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851855.

M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Clinical Psychology 6, 278296.

RH Howland , MG Wilson , SG Kornstein , AH Clayton , MH Trivedi , MM Wohlreich , M Fava (2008). Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression. Annals of Clinical Psychiatry 20, 209218.

NS Jacobson , KS Dobson , PA Truax , ME Addis , K Koerner , JK Gollan , E Gortner , SE Prince (1996). A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology 64, 295304.

PR Joyce , RT Mulder , JM McKenzie , SE Luty , CR Cloninger (2004). Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline. Depression and Anxiety 19, 180186.

A Korszun , V Moskvina , S Brewster , N Craddock , F Ferrero , M Gill , IR Jones , LA Jones , W Maier , O Mors , MJ Owen , M Preisig , T Reich , M Rietschel , A Farmer , P McGuffin (2004). Familiality of symptom dimensions in depression. Archives of General Psychiatry 61, 468474.

HC Kraemer , DJ Kupfer (2006). Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry 59, 990996.

AF Leuchter , IA Cook , WS Gilmer , LB Marangell , KS Burgoyne , RH Howland , MH Trivedi , S Zisook , R Jain , M Fava , D Iosifescu , S Greenwald (2009). Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research 169, 132138.

Y Leykin , JD Amsterdam , RJ DeRubeis , R Gallop , RC Shelton , SD Hollon (2007). Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology 75, 267276.

PJ McGrath , AY Khan , MH Trivedi , JW Stewart , DW Morris , SR Wisniewski , S Miyahara , AA Nierenberg , M Fava , JA Rush (2008). Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. Journal of Clinical Psychiatry 69, 18471855.

PJ McGrath , JW Stewart , MN Janal , E Petkova , FM Quitkin , DF Klein (2000). A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. American Journal of Psychiatry 157, 344350.

GE Mead , W Morley , P Campbell , CA Greig , M McMurdo , DA Lawlor (2009). Exercise for depression. Cochrane Database of Systematic Reviews (4), CD004366.

SA Montgomery , M Åsberg (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382389.

JC Nelson (2010). Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depression and Anxiety 27, 1218.

G Parker (2007). Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatrica Scandinavica. Supplementum (433), 2130.

G Parker , K Wilhelm , P Mitchell , K Roy , D Hadzi-Pavlovic (1999). Subtyping depression: testing algorithms and identification of a tiered model. Journal of Nervous and Mental Disease 187, 610617.

ES Paykel , PR Rowan , RR Parker , AV Bhat (1982). Response to phenelzine and amitriptyline in subtypes of outpatient depression. Archives of General Psychiatry 39, 10411049.

RH Perlis , A Patrick , JW Smoller , PS Wang (2009). When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study. Neuropsychopharmacology 34, 22272236.

PJ Perry (1996). Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders 39, 16.

JJ Prisciandaro , JE Roberts (2005). A taxometric investigation of unipolar depression in the National Comorbidity Survey. Journal of Abnormal Psychology 114, 718728.

CL Raison , AS Borisov , M Majer , DF Drake , G Pagnoni , BJ Woolwine , GJ Vogt , B Massung , AH Miller (2009). Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological Psychiatry 65, 296303.

NA Rasmussen , P Schroder , LR Olsen , M Brodsgaard , M Unden , P Bech (2005). Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Nordic Journal of Psychiatry 59, 173178.


AJ Rush , MH Trivedi , HM Ibrahim , TJ Carmody , B Arnow , DN Klein , JC Markowitz , PT Ninan , S Kornstein , R Manber , ME Thase , JH Kocsis , MB Keller (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573583.

AJ Rush , MH Trivedi , SR Wisniewski , AA Nierenberg , JW Stewart , D Warden , G Niederehe , ME Thase , PW Lavori , BD Lebowitz , PJ McGrath , JF Rosenbaum , HA Sackeim , DJ Kupfer , J Luther , M Fava (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163, 19051917.

JM Russell , LM Koran , J Rush , RM Hirschfeld , W Harrison , ES Friedman , S Davis , M Keller (2001). Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depression and Anxiety 13, 1827.

AF Schatzberg , AJ Rush , BA Arnow , PL Banks , JA Blalock , FE Borian , R Howland , DN Klein , JH Kocsis , SG Kornstein , R Manber , JC Markowitz , I Miller , PT Ninan , BO Rothbaum , ME Thase , MH Trivedi , MB Keller (2005). Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Archives of General Psychiatry 62, 513520.

GJ Siegle , SR Steinhauer , ES Friedman , WS Thompson , ME Thase (2011). Remission prognosis for cognitive therapy for recurrent depression using the pupil: utility and neural correlates. Biological Psychiatry 69, 726733.

JW Stewart , PJ McGrath , M Fava , SR Wisniewski , S Zisook , I Cook , AA Nierenberg , MH Trivedi , GK Balasubramani , D Warden , I Lesser , RA John (2010). Do atypical features affect outcome in depressed outpatients treated with citalopram? International Journal of Neuropsychopharmacology 13, 1530.

MJ Taylor , N Freemantle , JR Geddes , Z Bhagwagar (2006). Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry 63, 12171223.

ME Thase (2009). Atypical depression: useful concept, but it's time to revise the DSM-IV criteria. Neuropsychopharmacology 34, 26332641.


MH Trivedi , AJ Rush , SR Wisniewski , AA Nierenberg , D Warden , L Ritz , G Norquist , RH Howland , B Lebowitz , PJ McGrath , K Shores-Wilson , MM Biggs , GK Balasubramani , M Fava (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 2840.

R Uher , MZ Dernovsek , O Mors , J Hauser , D Souery , A Zobel , W Maier , N Henigsberg , P Kalember , M Rietschel , A Placentino , J Mendlewicz , KJ Aitchison , P McGuffin , A Farmer (2011). Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders 132, 112120.


R Uher , W Maier , J Hauser , A Marusic , C Schmael , O Mors , N Henigsberg , D Souery , A Placentino , M Rietschel , A Zobel , M Dmitrzak-Weglarz , A Petrovic , L Jorgensen , P Kalember , C Giovannini , M Barreto , A Elkin , S Landau , A Farmer , KJ Aitchison , P McGuffin (2009 a). Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. British Journal of Psychiatry 194, 252259.

R Uher , O Mors , J Hauser , M Rietschel , W Maier , D Kozel , N Henigsberg , D Souery , A Placentino , N Perroud , MZ Dernovsek , J Strohmaier , ER Larsen , A Zobel , A Leszczynska-Rodziewicz , P Kalember , L Pedrini , S Linotte , C Gunasinghe , KJ Aitchison , P McGuffin , A Farmer (2009 b). Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders 118, 147154.

G Veen , IN van Vliet , RH Derijk , EJ Giltay , J van Pelt , FG Zitman (2011). Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety. Psychiatry Research 185, 121128.

KJ Wardenaar , SA Vreeburg , T van Veen , EJ Giltay , G Veen , BW Penninx , FG Zitman (2011). Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis. Biological Psychiatry 69, 366373.

JK Wing , N Sartorius , TB Ustin (1998). Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN. World Health Organization: Geneva.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
UNKNOWN
Supplementary Materials

Uher Supplementary Material
Uher Supplementary Material

 Unknown (154 KB)
154 KB